跳至主要内容
临床试验/JPRN-UMIN000013076
JPRN-UMIN000013076已完成未知

Analysis of pathogenic role of soluble immune semaphorin in autoimmune diseases. - Semaphorin in autoimmune diseases

Osaka University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2014年2月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

evels of sSema4D were elevated in RA patients, and disease activities were correlated with serum levels of sSema4D. Treatment with an anti-Sema4D antibody suppressed arthritis in CIA. Levels of sSema4D were elevated in ANCA associated vasculitis patients. Neutrophil surface Sema4D functions as a negative regulator of neutrophil activation. Proteolytic cleavage of Sema4D as observed in patients with AAV may amplify neutrophil-mediated inflammatory responses.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • -complicated with active infectious diseases -The patients who the doctors in charge consider should not enter this study.

研究者

相似试验